Soluble ST2: a valuable prognostic marker in heart failure

被引:0
|
作者
Sugeevan Savarimuthu
Pavan Goel
Amer Harky
机构
[1] Basildon Hospital,Department of Medicine
[2] Liverpool Heart and Chest Hospital,Department of Pharmacy
[3] Liverpool Heart and Chest Hospital,Department of Cardiothoracic Surgery
来源
Heart Failure Reviews | 2022年 / 27卷
关键词
Heart failure; Soluble ST2; Natriuretic peptide; Biomarker;
D O I
暂无
中图分类号
学科分类号
摘要
Natriuretic peptides have been at the forefront of biomarker use in heart disease and have been universally recommended as the ideal biomarker in the setting of heart failure. Soluble ST2 is one such biomarker which has found value as a prognostic marker and can be used individually or along with natriuretic peptides in order to prognosticate patients with heart failure. Leading cardiovascular organisations have recognised this biomarker, though its role as a diagnostic marker is yet to be determined. We aim to investigate the role of sST2 in heart failure in the existing literature.
引用
收藏
页码:2155 / 2164
页数:9
相关论文
共 50 条
  • [41] Comparison of chromogranin A to proven biomarkers of natriuretic peptide, and ST2 as a prognostic marker in patients with acute heart failure
    Park, B. Boeun
    Jang, S. Y.
    Yang, D. H.
    Park, Y. J.
    Kim, H. N.
    Lee, J. H.
    Bae, M. H.
    Park, H. S.
    Cho, Y. G.
    Chae, S. C.
    Kim, N. K.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 257 - 257
  • [42] A DNA aptamer-based assay for the detection of soluble ST2, a prognostic biomarker for monitoring heart failure
    Gupta, Ankit
    Mathew, Roshan
    Anand, Anjali
    Bhardwaj, Tanu
    Singh, Aakriti
    Singh, Krishna
    Kumar, Amit
    Mishra, Prakash Ranjan
    Sharma, Tarun Kumar
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 256
  • [43] Soluble ST2 in Patients with Nonvalvular Atrial Fibrillation and Prediction of Heart Failure
    Chen, Changxi
    Qu, Xiang
    Gao, Zhan
    Zheng, Gaoshu
    Wang, Yi
    Chen, Xiao
    Li, Haiying
    Huang, Weijiang
    Zhou, Hao
    [J]. INTERNATIONAL HEART JOURNAL, 2018, 59 (01) : 58 - 63
  • [44] Soluble ST2 as a possible biomarker for inflammation in patients with acute heart failure
    Lai, Jiacheng
    Huang, Chongjian
    Li, Bin
    Han, Yongsheng
    [J]. JOURNAL OF CARDIOVASCULAR MEDICINE, 2024, 25 (03) : 186 - 192
  • [45] Soluble ST2 for Prognosis and Monitoring in Heart Failure The New Gold Standard?
    Bayes-Genis, Antoni
    Nunez, Julio
    Lupon, Josep
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (19) : 2389 - 2392
  • [46] Identification of serum soluble ST2 receptor as a novel heart failure biomarker
    Weinberg, EO
    Shimpo, M
    Hurwitz, S
    Tominaga, S
    Rouleau, JL
    Lee, RT
    [J]. CIRCULATION, 2003, 107 (05) : 721 - 726
  • [47] Association of Soluble ST2, an Emerging Biomarker of Heart Failure, with Peripartum Cardiomyopathy
    Rasmusson, Kismet
    Horne, Benjamin
    Brunisholz, Kim
    Januzzi, James
    Alharethi, Rami
    Budge, Deborah
    Galenko, Oxana
    Stehlik, Josef
    Carlquist, John
    Connollly, Jenny
    Frampton, Stacey
    Moore, Stephanie
    Kfoury, Abdallah
    [J]. JOURNAL OF CARDIAC FAILURE, 2011, 17 (08) : S85 - S85
  • [48] Soluble ST2 protein in chronic heart failure is independent of traditional factors
    Wojtczak-Soska, Karolina
    Pietrucha, Tadeusz
    Sakowicz, Agata
    Lelonek, Malgorzata
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2013, 9 (01) : 21 - 26
  • [49] Soluble ST2 in the prediction of heart failure and death in patients with atrial fibrillation
    Krittayaphong, Rungroj
    Pumprueg, Satchana
    Sairat, Poom
    [J]. CLINICAL CARDIOLOGY, 2022, 45 (04) : 447 - 456
  • [50] Soluble ST2 proteins in male cachectic patients with chronic heart failure
    Sobieszek, Grzegorz
    Powrozek, Tomasz
    Jaroszynski, Andrzej
    Skwarek-Dziekanowska, Aneta
    Rahnama-Hezavah, Mansur
    Malecka-Massalska, Teresa
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2021, 31 (03) : 886 - 893